Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Trading Down 0.3% – Here’s What Happened

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)’s share price was down 0.3% during mid-day trading on Tuesday . The stock traded as low as $36.23 and last traded at $36.37. Approximately 1,005 shares traded hands during trading, a decline of 46% from the average daily volume of 1,861 shares. The stock had previously closed at $36.49.

Innovator IBD Breakout Opportunities ETF Stock Performance

The firm has a market cap of $10.91 million, a PE ratio of 28.69 and a beta of 1.08. The stock’s 50 day simple moving average is $37.45 and its 200 day simple moving average is $37.35.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

Several hedge funds have recently added to or reduced their stakes in the company. Susquehanna International Group LLP boosted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 42.6% in the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares in the last quarter. Comprehensive Wealth Management LLC lifted its position in Innovator IBD Breakout Opportunities ETF by 60.5% in the 3rd quarter. Comprehensive Wealth Management LLC now owns 10,544 shares of the company’s stock worth $411,000 after buying an additional 3,976 shares during the last quarter. Osaic Holdings Inc. boosted its stake in Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after buying an additional 597 shares in the last quarter. Finally, Nova Wealth Management Inc. grew its position in Innovator IBD Breakout Opportunities ETF by 109.4% during the first quarter. Nova Wealth Management Inc. now owns 23,978 shares of the company’s stock valued at $870,000 after acquiring an additional 12,528 shares during the last quarter.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.